AU
UK
CA
NZ
IND
US
A Platform in Peril
The Approval Catalyst and Market Positioning
A Rally Built on Relief, Not Resolution
The Regenerative Medicine Moment
Key Highlights
Co-Diagnostics, Inc. (Nasdaq: CODX) shares surged more than 10% in pre-market trading on Thursday after the molecular diagnostics company announced progress in its PCR assay development strategy targeting the Bundibugyo virus (BDBV), an ebolavirus strain currently linked to outbreaks in the Democratic Republic of …
Key Highlights
CVS Health (NYSE:CVS) announced on Thursday that its pharmacy benefits arm, CVS Caremark, will expand coverage of GLP-1 weight management therapies by reinstating Eli Lilly's (NYSE:LLY) Zepbound injection and adding Foundayo, the company's newly approved oral obesity pill. The announcement marks a significant strategic …
Please wait processing your request...